Michael Feld's Sale of Becton Dickinson & Co. Common Stock

Michael Feld, EVP & President of Life Sciences at Becton Dickinson & Co., sold 57 shares of the company's common stock on October 27, 2025, at a price of $186.01 per share. This transaction was executed under a Rule 10b5-1 trading plan, which was adopted on February 7, 2025. Following the sale, Feld owns 8,245 shares of the company's common stock. The transaction was reported in a Form 4 filing with the SEC.